Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Correlating Fecal Calprotectin With Hemoglobin Levels Within 1 Sample.

Fuhler GM, van der Giessen J, van der Woude CJ, Peppelenbosch MP.

Inflamm Bowel Dis. 2018 Feb 15;24(3):663. doi: 10.1093/ibd/izx028. No abstract available.

PMID:
29462378
2.

Fecal hemoglobin and calprotectin are equally effective in identifying patients with inflammatory bowel disease with active endoscopic inflammation.

Mooiweer E, Fidder HH, Siersema PD, Laheij RJ, Oldenburg B.

Inflamm Bowel Dis. 2014 Feb;20(2):307-14. doi: 10.1097/01.MIB.0000438428.30800.a6.

PMID:
24374878
3.

FECAL CALPROTECTIN: levels for the ethiological diagnosis in Brazilian patients with gastrointestinal symptoms.

Kotze LM, Nisihara RM, Marion SB, Cavassani MF, Kotze PG.

Arq Gastroenterol. 2015 Jan-Mar;52(1):50-4. doi: 10.1590/S0004-28032015000100011.

4.

The utility of fecal calprotectin in predicting the need for escalation of therapy in inflammatory bowel disease.

Kwapisz L, Gregor J, Chande N, Yan B, Ponich T, Mosli M.

Scand J Gastroenterol. 2017 Aug;52(8):846-850. doi: 10.1080/00365521.2017.1315740. Epub 2017 Apr 20.

PMID:
28423962
5.

Correspondence: fecal calprotectin and cut-off levels in inflammatory bowel disease.

Kristensen V, Moum B.

Scand J Gastroenterol. 2015;50(9):1183-4. doi: 10.3109/00365521.2015.1025830. Epub 2015 Mar 15. No abstract available.

PMID:
25772406
6.

Diagnostic value of calprotectin in irritable bowel syndrome and in inflammatory bowel disease.

Grad C, David L, Portincasa P, Dumitraşcu DL.

Rom J Intern Med. 2012 Jan-Mar;50(1):3-6. Review.

PMID:
22788087
7.

Fecal leukocyte proteins in inflammatory bowel disease and irritable bowel syndrome.

Silberer H, Küppers B, Mickisch O, Baniewicz W, Drescher M, Traber L, Kempf A, Schmidt-Gayk H.

Clin Lab. 2005;51(3-4):117-26.

PMID:
15819166
8.

Diagnostic power of fecal calprotectin in inflammatory and functional intestinal disorders.

Agilli M, Aydin FN, Gulcan Kurt Y, Cayci T.

Scand J Gastroenterol. 2015 Mar;50(3):376-7. doi: 10.3109/00365521.2014.999114. Epub 2015 Jan 13. No abstract available.

PMID:
25582762
9.

Fecal S100A12 and fecal calprotectin as noninvasive markers for inflammatory bowel disease in children.

Sidler MA, Leach ST, Day AS.

Inflamm Bowel Dis. 2008 Mar;14(3):359-66.

PMID:
18050298
10.

Fecal calprotectin does not predict endoscopic remission in inflammatory bowel disease.

Falvey JD, Gearry RB, Day AS.

Inflamm Bowel Dis. 2013 May;19(6):E80-1. doi: 10.1097/MIB.0b013e31828dc6d3. No abstract available.

PMID:
23619719
11.

Infliximab in pediatric inflammatory bowel disease rapidly decreases fecal calprotectin levels.

Hämäläinen A, Sipponen T, Kolho KL.

World J Gastroenterol. 2011 Dec 21;17(47):5166-71. doi: 10.3748/wjg.v17.i47.5166.

12.

Role of fecal calprotectin test in the work-up of IBS patients.

Delgado-Aros S, Cremonini F.

Gastroenterology. 2003 Apr;124(4):1164-5. No abstract available.

PMID:
12671919
13.

[Fecal calprotectin].

Rodrigo L.

Rev Esp Enferm Dig. 2007 Dec;99(12):683-8. Review. Spanish. No abstract available.

14.
15.

Fecal calprotectin in pediatric inflammatory bowel disease: a systematic review.

Kostakis ID, Cholidou KG, Vaiopoulos AG, Vlachos IS, Perrea D, Vaos G.

Dig Dis Sci. 2013 Feb;58(2):309-19. doi: 10.1007/s10620-012-2347-5. Epub 2012 Aug 17. Review.

PMID:
22899243
16.

Reply to: Diagnostic power of fecal calprotectin in inflammatory and functional intestinal disorders.

Caviglia GP, Pellicano R, Astegiano M.

Scand J Gastroenterol. 2015 May;50(5):623-4. doi: 10.3109/00365521.2014.1002527. Epub 2015 Mar 3. No abstract available.

PMID:
25737251
17.

Fecal calprotectin: controlling the cost of care.

Abraham BP, Sellin JH.

Clin Gastroenterol Hepatol. 2014 Feb;12(2):263-4. doi: 10.1016/j.cgh.2013.09.018. Epub 2013 Sep 18. No abstract available.

PMID:
24055986
18.

Fecal calprotectin in inflammatory bowel diseases: update and perspectives.

Manceau H, Chicha-Cattoir V, Puy H, Peoc'h K.

Clin Chem Lab Med. 2017 Mar 1;55(4):474-483. doi: 10.1515/cclm-2016-0522. Review.

19.

Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.

D'Haens G, Ferrante M, Vermeire S, Baert F, Noman M, Moortgat L, Geens P, Iwens D, Aerden I, Van Assche G, Van Olmen G, Rutgeerts P.

Inflamm Bowel Dis. 2012 Dec;18(12):2218-24. doi: 10.1002/ibd.22917. Epub 2012 Feb 16.

PMID:
22344983
20.

A novel turbidimetric immunoassay for fecal calprotectin optimized for routine chemistry analyzers.

Nilsen T, Sunde K, Hansson LO, Havelka AM, Larsson A.

J Clin Lab Anal. 2017 Jul;31(4). doi: 10.1002/jcla.22061. Epub 2016 Sep 15.

PMID:
27629827

Supplemental Content

Support Center